Lisa A. Cannon-Albright, PhD

Research Interests

  • Disease Predisposition Genes
  • Population-Based Studies

Languages

  • English

Academic Information

  • Departments: Family & Preventive Medicine - Adjunct Professor, Internal Medicine - Professor
  • Divisions: Epidemiology, Public Health
  • Cancer Center Programs: Cancer Control & Population Sciences

Academic Office Information

  • 801-587-9300
  • Division of Genetic Epidemiology
    391 Chipeta, Way, Suite D
    Salt Lake City, UT 84108

Academic Bio

Dr. Lisa Cannon-Albright is Professor and Division Chief of the Division of Genetic Epidemiology in the Department of Medicine at the University of Utah School of Medicine. She is a Huntsman Cancer Institute investigator and a member of the Cancer Control and Population Sciences program. As a Genetic Epidemiologist her research interests include computerized genealogy data, high risk pedigree studies, and predisposition gene identification.

Dr. Albright has over 3 decades of experience in designing and directing studies of high-risk pedigrees to identify genes predisposing to cancer and other diseases. Genes identified in Utah high risk pedigree studies include NF (Barker et al.); Alport Syndrome (Atkins et al): BRCA1 (Miki et al, 1994); BRCA2 (Tavtigian et al, 1996); p16 (Kamb et al, 1994; Cannon-Albright et al., 1994); and ELAC2/PRCA2 (Tavtigian et al., 2001). Dr. Albright’s research goals are to identify and understand predisposition genes for common traits. Her research group accomplishes this primarily through analysis of genealogy data and the study of extended Utah high-risk pedigrees. She currently directs and is involved in cancer studies of prostate cancer, pancreas cancer, Ewings sarcoma, melanoma, pelvic floor disorders, colorectal cancer, and the exploration of new population-based resources. Her work is sponsored by the National Institutes of Health, the University of Utah, AACR, Alex’s Lemonade Stand, the Huntsman Cancer Institute, and the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.

Dr. Albright has over 3 decades of experience analyzing a unique computerized genealogy of Utah, linked to medical data, to describe the heritable contribution to various health-related phenotypes including cancer, influenza mortality, asthma mortality, aneurysm, heart disease, diabetes, and rotator disease (Cannon et al., 1982, Cannon-Albright et al., 1994; 2003; 2005, Horne et al., 2005, 2006; Teerlink et al., 2007; Albright et al., 2008; Weires et al., 2005; Tashjian et al., 2009), among others. Dr. Albright continues to explore many different phenotypes using the UPDB. She is currently collaborating on the following phenotypes: head and neck cancers, lung cancer, ataxias, Alzheimers, spinal disorders, neurofibromatosis, celiac disease, influenza, asthma, thinness, tendonopathies, benign pituitary tumors, stroke, auto-immune disease, gallstone disease, sepsis, stroke, skeletal injury, and osteoarthritis.

Dr. Albright has recently built the genealogy of Utah and Massachusetts and record linked this genealogy to VA patients served in these states. This is part of a long-term plan to build the US genealogy and link to all 24 million VA patients nationwide.

Dr. Albright is interested in exploring new approaches and has directed a collaboration to develop analyses using high density SNP data to identify regions identical by descent within and between individuals in search of predisposition genes (Thomas et al., 2008). She has developed an innovative approach of mining existing tissue resources to obtain germline DNA for affected members of high-risk pedigrees to enable genetic studies for diseases that are quickly lethal.

Education History

Type School Degree
Doctoral Training University of Utah
Genetic Epidemiology/Biomedical Informatics
Ph.D.
Graduate Training University of Utah
Biostatistics
M.Stat
Undergraduate Brigham Young University
Statistics
B.S.

Global Impact

Presentations

Description Country
Utah High Risk Asthma Pedigree Study, AllerGen Gene Environment Asthma Workshop, Vancouver, Canada. Canada
Genetic heterogeneity of prostate cancer, Prostate Cancer Charitable Trust, Oxford Meeting, Hertford College, Oxford, England. United Kingdom
Utah genealogical database. Family Based Studies and Genetic Epidemiology:Theory and Practice Symposium, Sheffield, England. United Kingdom
Prostate cancer studies in Utah and the 22q locus. Prostate Cancer Research Foundation Symposium, London, England. United Kingdom

Selected Publications

Journal Article

  1. Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA (2018). Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).LID - S0190-9622(18)30341-4 [pii]LID - 10.1016/j.jaad.2018.02.055 [doi]. (Epub ahead of print) J Am Acad Dermatol.
  2. Teerlink CC, Huff C, Stevens J, Yu Y, Holmen SL, Silvis MR, Trombetti K, Zhao H, Grossman D, Farnham JM, Wen J, Facelli JC, Thomas A, Babst M, Florell SR, Meyer L, Zone JJ, Leachman S, Cannon-Albright LA (2018). A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.LID - 10.1093/jnci/djy058 [doi]. (Epub ahead of print) J Natl Cancer Inst.
  3. Hahn AW, Gill DM, Nussenzveig RH, Poole A, Farnham J, Cannon-Albright L, Agarwal N (2018). Germline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate Cancer.LID - S1558-7673(18)30215-5 [pii]LID - 10.1016/j.clgc.2018.03.006 [doi]. (Epub ahead of print) Clin Genitourin Cancer.
  4. Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Gronberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Roder MA, Iversen P, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Cuk K, Saum KU, Park JY, Sellers TA, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Karow DS, Mills IG, Andreassen OA, Dale AM (2018). Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. BMJ, 360, j5757.
  5. Monroe MM, Hashibe M, Orb Q, Alt J, Buchmann L, Hunt J, Cannon-Albright LA (2018). Familial clustering of oropharyngeal squamous cell carcinoma in the Utah population. Head Neck, 40(2), 384-393.
  6. Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM, Cheng CH, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Batra J, Teixeira MR, Pandha H, Lu YJ, Park JY (2017). SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns. Bioinformatics, 33(6), 822-833.
  7. Agarwal N, Hahn AW, Gill DM, Farnham JM, Poole AI, Cannon-Albright L (2017). Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer. JAMA Oncol, 3(6), 856-857.
  8. Larson NB, McDonnell S, Cannon Albright L, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E, Schleutker J, Carpten JD, Powell I, Bailey-Wilson JE, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Whittemore AS, Hsieh CL, Wiklund F, Catolona WJ, Foulkes W, Mandal D, Eeles R, Kote-Jarai Z, Ackerman MJ, Olson TM, Klein CJ, Thibodeau SN, Schaid DJ (2017). gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels. Genet Epidemiol, 41(4), 297-308.
  9. Abbott D, Brockmeyer D, Neklason DW, Teerlink C, Cannon-Albright LA (2017). Population-based description of familial clustering of Chiari malformation Type I. J Neurosurg, 1-6.
  10. Samadder NJ, Smith KR, Wong J, Thomas A, Hanson H, Boucher K, Kopituch C, Cannon-Albright LA, Burt RW, Curtin K (2017). Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome. JAMA Oncol, 3(12), 1697-1701.
  11. Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Hoiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Peric B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA (2017). Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. J Invest Dermatol, 137(12), 2606-2612.
  12. Barrott JJ, Zhu JF, Smith-Fry K, Susko AM, Nollner D, Burrell LD, Pozner A, Capecchi MR, Yap JT, Cannon-Albright LA, Deng X, Jones KB (2017). The Influential Role of BCL2 Family Members in Synovial Sarcomagenesis. Mol Cancer Res, 15(12), 1733-1740.
  13. Teerlink CC, Bernhisel R, Cannon-Albright LA, Rollins MD (2017). A population-based description of familial clustering of Hirschsprung's disease.LID - S0022-3468(17)30520-1 [pii]LID - 10.1016/j.jpedsurg.2017.08.024 [doi]. (Epub ahead of print) J Pediatr Surg.
  14. Couldwell WT, Cannon-Albright LA (2017). A description of familial clustering of meningiomas in the Utah population. Neuro Oncol, 19(12), 1683-1687.
  15. Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Gonzalez Murcia JD, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, Hardy J, Munger R, Norton M, Sassi C, Singleton A, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Cruchaga C, Goate AM, Corcoran C, Tschanz J, Cannon-Albright LA, Kauwe JSK (2017). Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome Med, 9(1), 100.
  16. Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Donovan J, Hamdy FC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zuccolo L (2017). Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study. Int J Cancer, 140(1), 75-85.
  17. Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Blot W, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Donovan J, Munafo MR (2017). Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. Int J Cancer, 140(2), 322-328.
  18. Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, Gentry-Maharaj A, Whittemore AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A, Ziogas A, Ekici AB, Burwinkel B, Karlan BY, Nordestgaard BG, Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Stegmaier C, Maier C, Ambrosone CB, Hogdall CK, Teerlink CC, Kang D, Tessier DC, Schaid DJ, Stram DO, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, Hogdall E, Song F, Bruinsma F, Heitz F, Modugno F, Hamdy FC, Wiklund F, Giles GG, Olsson H, Wildiers H, Ulmer HU, Pandha H, Risch HA, Darabi H, Salvesen HB, Nevanlinna H, Gronberg H, Brenner H, Brauch H, Anton-Culver H, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, Lubinski J, Stanford JL, Benitez J, Doherty JA, Permuth JB, Chang-Claude J, Donovan JL, Dennis J, Schildkraut JM, Schleutker J, Hopper JL, Kupryjanczyk J, Park JY, Figueroa J, Clements JA, Knight JA, Peto J, Cunningham JM, Pow-Sang J, Batra J, Czene K, Lu KH, Herkommer K, Khaw KT, Matsuo K, Muir K, Offitt K, Chen K, Moysich KB, Aittomaki K, Odunsi K, Kiemeney LA, Massuger LF, Fitzgerald LM, Cook LS, Cannon-Albright L, Hooning MJ, Pike MC, Bolla MK, Luedeke M, Teixeira MR, Goodman MT, Schmidt MK, Riggan M, Aly M, Rossing MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Lush M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N, Le ND, Orr N, Wentzensen N, Pashayan N, Peterlongo P, Guenel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud RK, Schmutzler RK, Stephenson RA, MacInnis RJ, Hoover RN, Winqvist R, Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell SK, Tworoger SS, Maia S, Berndt S, Lee SC, Teo SH, Thibodeau SN, Bojesen SE, Gapstur SM, Kjaer SK, Pejovic T, Tammela TL, Dork T, Bruning T, Wahlfors T, Key TJ, Edwards TL, Menon U, Hamann U, Mitev V, Kosma VM, Setiawan VW, Kristensen V, Arndt V, Vogel W, Zheng W, Sieh W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman ML, Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, Gayther SA, Easton DF, Chenevix-Trench G, Eeles R, Pharoah PD, Lambrechts D (2016). Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov, 6(9), 1052-67.
  19. Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Donovan JL, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zheng W (2016). Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. Br J Cancer, 115(5), 624-31.
  20. Southey MC, Goldgar DE, Winqvist R, Pylkas K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dork T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guenel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menendez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Bruning T, Ko YD, Muranen TA, Aittomaki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K, Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnaes GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila S, Devilee P, Tollenaar RA, Seynaeve C, Hollestelle A, Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens JW, Collee JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres D, Ulmer HU, Rudiger T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A, Ashworth A, Orr N, Jones M, Gonzalez-Neira A, Pita G, Alonso MR, Alvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Butterbach K, Park J, Kaneva R, Batra J, Teixeira MR, Kote-Jarai Z, Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A, Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K, Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Edwards RP, Ness RB, Moysich KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Hogdall E, Peissel B, Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer M, Tworoger SS, Bandera EV, Orlow I, Olson SH, Bjorge L, Salvesen HB, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Gorski B, Gronwald J, Menkiszak J, Hogdall CK, Lundvall L, Nedergaard L, Engelholm SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Song H, Winship I, Chenevix-Trench G, Giles GG, Tavtigian SV, Easton DF, Milne RL (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet, 53(12), 800-811.
  21. Luedeke M, Rinckleb AE, FitzGerald LM, Geybels MS, Schleutker J, Eeles RA, Teixeira MR, Cannon-Albright L, Ostrander EA, Weikert S, Herkommer K, Wahlfors T, Visakorpi T, Leinonen KA, Tammela TL, Cooper CS, Kote-Jarai Z, Edwards S, Goh CL, McCarthy F, Parker C, Flohr P, Paulo P, Jeronimo C, Henrique R, Krause H, Wach S, Lieb V, Rau TT, Vogel W, Kuefer R, Hofer MD, Perner S, Rubin MA, Agarwal AM, Easton DF, Amin Al Olama A, Benlloch S, Hoegel J, Stanford JL, Maier C (2016). Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.LID - ddw349 [pii]. (Epub ahead of print) Hum Mol Genet.
  22. Albright FS, Stephenson RA, Agarwal N, Cannon-Albright LA (2016). Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death.LID - 10.1002/pros.23247 [doi]. (Epub ahead of print) Prostate.
  23. Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Singhal S, Pawlish K, Peters ES, Bock CH, Stram A, Van Den Berg DJ, Edlund CK, Conti DV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A, Kong Y, Pregja SL, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber MR, Goodman PJ, Hennis AJ, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy AB, Nemesure B, Neslund-Dudas C, Strom SS, Vij R, Rybicki BA, Stanford JL, Signorello LB, Witte JS, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Birmann BM, Ingles SA, Press MF, Atanackovic D, Glenn MJ, Cannon-Albright LA, Jones B, Tricot G, Martin TG, Kumar SK, Wolf JL, Deming Halverson SL, Rothman N, Brooks-Wilson AR, Rajkumar SV, Kolonel LN, Chanock SJ, Slager SL, Severson RK, Janakiraman N, Terebelo HR, Brown EE, De Roos AJ, Mohrbacher AF, Colditz GA, Giles GG, Spinelli JJ, Chiu BC, Munshi NC, Anderson KC, Levy J, Zonder JA, Orlowski RZ, Lonial S, Camp NJ, Vachon CM, Ziv E, Stram DO, Hazelett DJ, Haiman CA, Cozen W (2016). A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev, 25(12), 1609-1618.
  24. Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA, Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM, Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ, Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN, Whittemore AS, Sieh W (2016). REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet, 99(4), 877-885.
  25. Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquires H, McKay J, Conde L, de Bakker PI, Cox DG, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J, Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing H, Tjnneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Liang L, Park JH, Chung CC, Weisenburger DD, Fraumeni JF Jr, Salles G, Glenn M, Cannon-Albright L, Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt SI, Birmann BM, Chanock SJ, Rothman N (2016). Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet, 25(8), 1663-76.
  26. Agarwal N, Alex AB, Farnham JM, Patel S, Gill D, Buckley TH, Stephenson RA, Cannon-Albright L (2016). Inherited variants in SULT1E1 and response to abiraterone acetate in men with metastatic castration refractory prostate cancer (mCRPC).LID - S0022-5347(16)30328-7 [pii]LID - 10.1016/j.juro.2016.04.079 [doi]. (Epub ahead of print) J Urol.
  27. Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2016). Population-based risks for cancer in patients with ALS.LID - 10.1212/WNL.0000000000002757 [pii]. (Epub ahead of print) Neurology.
  28. Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Smith GD, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Martin RM, Holly JM (2016). Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.LID - 10.1002/ijc.30206 [doi]. (Epub ahead of print) Int J Cancer.
  29. Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Giles GG, Southey MC, Fitzgerald LM, Rinckleb A, Luedeke M, Maier C, Stanford JL, Ostrander EA, Kaikkonen EM, Sipeky C, Tammela T, Schleutker J, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cancel-Tassin G, Cussenot O, Mandal D, Laurie C, Laurie C, Thibodeau SN, Eeles RA, Kote-Jarai Z, Cannon-Albright L (2016). Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. (Epub ahead of print) Hum Genet.
  30. Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Davey Smith G (2016). Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC Med, 14(1), 66.
  31. Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, Carpten J, Leske MC, Wu SY, Hennis AJ, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Witte JS, Casey G, Kaggwa S, Cook MB, Stram DO, Blot WJ, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Gronberg H, Wiklund F, Aly M, Henderson BE, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Teerlink C, Brenner H, Dieffenbach AK, Arndt V, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA, Teixeira MR, Pandha H, Michael A, Paulo P, Maia S, Kierzek A, Conti DV, Albanes D, Berg C, Berndt SI, Campa D, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giovannucci E, Hoover R, Hunter DJ, Johansson M, Kraft P, Le Marchand L, Lindstrom S, Navarro C, Overvad K, Riboli E, Siddiq A, Stevens VL, Trichopoulos D, Vineis P, Yeager M, Trynka G, Raychaudhuri S, Schumacher FR, Price AL, Freedman ML, Haiman CA, Pasaniuc B (2016). Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat Commun, 7, 10979.
  32. Abbott D, Johnson NE, Cannon-Albright LA (2016). A Population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.LID - 10.1002/mus.25145 [doi]. (Epub ahead of print) Muscle Nerve.
  33. Tashjian RZ, Granger EK, Zhang Y, Teerlink CC, Cannon-Albright LA (2016). Identification of a genetic variant associated with rotator cuff repair healing. J Shoulder Elbow Surg, 25(6), 865-72.
  34. Tashjian RZ, Farnham JM, Granger EK, Teerlink CC, Cannon-Albright LA (2016). Evidence for an Environmental and Inherited Predisposition Contributing to the Risk for Global Tendinopathies or Compression Neuropathies in Patients With Rotator Cuff Tears. Orthop J Sports Med, 4(4), 2325967116642173.
  35. Savica R, Cannon-Albright LA, Pulst S (2016). Familial aggregation of Parkinson disease in Utah: A population-based analysis using death certificates. Neurol Genet, 2(2), e65.
  36. Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras LR, Machado M, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Vajdic CM, Cocco P, Zhang Y, Giles GG, Zeleniuch-Jacquotte A, Lawrence C, Montalvan R, Burdett L, Hutchinson A, Ye Y, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Cunningham JM, Allmer C, Hjalgrim H, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Arnett DK, Zhi D, Leach JM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Sala N, Casabonne D, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Chaffee KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Leis JF, Weinberg JB, Caporaso NE, Norman AD, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Southey MC, Milne RL, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Villano DJ, Maria A, Spinelli JJ, Gascoyne RD, Connors JM, Bertrand KA, Giovannucci E, Kraft P, Kricker A, Turner J, Ennas MG, Ferri GM, Miligi L, Liang L, Ma B, Huang J, Crouch S, Park JH, Chatterjee N, North KE, Snowden JA, Wright J, Fraumeni JF, Offit K, Wu X, de Sanjose S, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2016). Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun, 7, 10933.
  37. Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K, Easton DF, Eeles RA, Kote-Jarai Z (2016). Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.LID - 10.1038/bjc.2016.50 [doi]. (Epub ahead of print) Br J Cancer.
  38. Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OH, Richards JB, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, MacInnis RJ, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Micheal A, Pandha H, Smith GD, Lewis SJ, Martin RM (2016). Blood lipids and prostate cancer: a Mendelian randomization analysis.LID - 10.1002/cam4.695 [doi]. (Epub ahead of print) Cancer Med.
  39. Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Hoiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Peric B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KA, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA (2016). Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. J Invest Dermatol, 136(5), 1066-9.
  40. Camp NJ, Lin WY, Bigelow A, Burghel GJ, Mosbruger TL, Parry MA, Waller RG, Rigas SH, Tai PY, Berrett K, Rajamanickam V, Cosby R, Brock IW, Jones B, Connley D, Sargent R, Wang G, Factor RE, Bernard PS, Cannon-Albright L, Knight S, Abo R, Werner TL, Reed MW, Gertz J, Cox A (2016). Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Res, 76(7), 1916-25.
  41. Neklason DW, VanDerslice J, Curtin K, Cannon-Albright LA (2016). Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer, 23(2), 93-100.
  42. Morgan TK, Allen-Brady KL, Monson MA, Leclair CM, Sharp HT, Cannon-Albright LA (2016). Familiality analysis of provoked vestibulodynia treated by vestibulectomy supports genetic predisposition. Am J Obstet Gynecol, 214(5), 609.e1-7.
  43. Tashjian RZ, Granger EK, Farnham JM, Cannon-Albright LA, Teerlink CC (2016). Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms. J Shoulder Elbow Surg, 25(2), 174-9.
  44. Panagiotou OA, Travis RC, Campa D, Berndt SI, Lindstrom S, Kraft P, Schumacher FR, Siddiq A, Papatheodorou SI, Stanford JL, Albanes D, Virtamo J, Weinstein SJ, Diver WR, Gapstur SM, Stevens VL, Boeing H, Bueno-de-Mesquita HB, Barricarte Gurrea A, Kaaks R, Khaw KT, Krogh V, Overvad K, Riboli E, Trichopoulos D, Giovannucci E, Stampfer M, Haiman C, Henderson B, Le Marchand L, Gaziano JM, Hunter DJ, Koutros S, Yeager M, Hoover RN, PRACTICAL Consortium, Chanock SJ, Wacholder S, Key TJ, Tsilidis KK (2015). A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol, 67(4), 649-57.
  45. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Juul Vangsted A, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015). Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun, 6, 10203.
  46. Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Smith GD, Martin RM (2015). The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control, 26(11), 1603-16.
  47. Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald LM, Henderson BE, Schumacher FR, Haiman CA, Sipeky C, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubinski J, Kluzniak W, Cannon-Albright L, Brenner H, Herrmann V, Holleczek B, Park JY, Sellers TA, Lim HY, Slavov C, Kaneva RP, Mitev VI, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Batra J, Clements JA, Albanes D, Andriole GL, Berndt SI, Chanock S, Gapstur SM, Giovannucci EL, Hunter DJ, Kraft P, Le Marchand L, Ma J, Mondul AM, Penney KL, Stampfer MJ, Stevens VL, Weinstein SJ, Trichopoulou A, Bueno-de-Mesquita BH, Tjonneland A, Cox DG, Maehle L, Schleutker J, Lindstrom S, Wiklund F (2015). Genome-wide association study of prostate cancer-specific survival. Cancer Epidemiol Biomarkers Prev, 24(11), 1796-800.
  48. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015). Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun, 6, 7539.
  49. Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai ZS, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubinski J, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Stegmaier C, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Gronberg H, Wiklund F (2015). Prediction of individual genetic risk to prostate cancer using a polygenic score. Prostate, 75(13), 1467-74.
  50. Carr SR, Akerley W, Hashibe M, Cannon-Albright LA (2015). Evidence for a genetical contribution to non-smoking-related lung cancer. Thorax, 70(11), 1033-9.
  51. Johnson NE, Abbott D, Cannon-Albright LA (2015). Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis. Muscle Nerve, 52(4), 659-61.
  52. Pelt CE, Erickson JA, Peters CL, Anderson MB, Cannon-Albright L (2015). A Heritable Predisposition to Osteoarthritis of the Hip. J Arthroplasty, 30(9 Suppl), 125-9.
  53. Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Vinuela A, Brown AA, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z (2015). Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet, 24(19), 5589-602.
  54. Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney KA, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF (2015). Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev, 24(7), 1121-9.
  55. Stegeman S, Amankwah E, Klein K, OMara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, Spurdle AB, Clements JA, Park JY, Batra J (2015). A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. Cancer Discov, 5(4), 368-79.
  56. Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Fontham ET, Smith G, Mohler JL, Berndt SI, McDonnell SK, Kittles R, Rybicki BA, Freedman M, Kantoff PW, Pomerantz M, Breyer JP, Smith JR, Rebbeck TR, Mercola D, Isaacs WB, Wiklund F, Cussenot O, Thibodeau SN, Schaid DJ, Cannon-Albright L, Cooney KA, Chanock SJ, Stanford JL, Chan JM, Witte J, Xu J, Bensen JT, Taylor JA, Catalona WJ (2015). Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet, 134(4), 439-50.
  57. Albright F, Stephenson RA, Agarwal N, Teerlink CC, Lowrance WT, Farnham JM, Cannon-Albright LA (2015). Prostate cancer risk prediction based on complete prostate cancer family history. Prostate, 75(4), 390-8.
  58. Allen-Brady K, Norton PA, Cannon-Albright L (2015). Risk of associated conditions in relatives of subjects with interstitial cystitis. Female Pelvic Med Reconstr Surg, 21(2), 93-8.
  59. Norton PA, Allen-Brady K, Wu J, Egger M, Cannon-Albright L (2015). Clinical characteristics of women with familial pelvic floor disorders. Int Urogynecol J, 26(3), 401-6.
  60. Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Rogaeva E, Lin CF, Dombroski BA, Cantwell LB, Partch A, Valladares O, Hakonarson H, St George-Hyslop P, Green RC, Goate AM, Foroud TM, Carney RM, Larson EB, Behrens TW, Kauwe JS, Haines JL, Farrer LA, Pericak-Vance MA, Mayeux R, Schellenberg GD, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barmada M, Barnes LL, Beach TG, Becker JT, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carroll SL, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Demirci FY, Dick M, Dickson DW, Duara R, Ertekin-Taner N, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Graff-Radford NR, Growdon JH, Hamilton RL, Hamilton-Nelson KL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Jun G, Kamboh MI, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lopez OL, Lunetta KL, Lyketsos CG, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam WM, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Murrell JR, Olichney JM, Parisi JE, Perry W, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L (2015). Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol, 72(2), 209-16.
  61. Allen-Brady K, Cannon-Albright LA, Farnham JM, Norton PA (2015). Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17. Am J Obstet Gynecol, 212(6), 771.e1-7.
  62. Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen GM (2015). BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med, 17(7), 569-77.
  63. Teerlink CC, Cannon-Albright LA, Tashjian RZ (2015). Significant association of full-thickness rotator cuff tears and estrogen-related receptor-beta (ESRRB). J Shoulder Elbow Surg, 24(2), e31-5.
  64. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Roder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokolorczyk D, Kluzniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA (2014). A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet, 46(10), 1103-9.
  65. Couldwell WT, Cannon-Albright LA (2014). Co-prevalence of other tumors in patients harboring pituitary tumors. J Neurosurg, 121(6), 1474-7.
  66. Teerlink C, Nelson Q, Burt R, Cannon-Albright L (2014). Significant evidence of linkage for a gene predisposing to colorectal cancer and multiple primary cancers on 22q11. Clin Transl Gastroenterol, 5, e50.
  67. Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Severi G, Gronberg H, Aly M, Haiman CA, Schumacher F, Henderson BE, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Nordestgaard BG, Canzian F, Campa D, Riboli E, Key TJ, Travis RC, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Clements JA, Teixeira MR, Xu J, Mikropoulos C, Goh C, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Easton DF, Muir K, Eeles RA, Kote-Jarai Z (2014). Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet, 10(2), e1004129.
  68. Teerlink C, Nelson Q, Burt R, Cannon-Albright LA (2014). Analysis of high-risk pedigrees identifies significant evidence for linkage for a predisposition gene for colorectal cancer and multiple primary cancers on chromosome 22q11. Clin Transl Gastroenterol, 5, e50.
  69. Cannon-Albright LA, Farnham JM, Bailey M, Albright FS, Teerlink CC, Agarwal N, Stephenson RA, Thomas A (2014). Identification of specific Y chromosomes associated with increased prostate cancer risk. Prostate, 74(9), 991-8.
  70. Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2014). Familial clustering of ALS in a population-based resource. Neurology, 82(1), 17-22.
  71. Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Gronberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J, Camp NJ, Cannon-Albright LA (2014). Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet, 133(3), 347-56.
  72. Yu OH, Foulkes WD, Dastani Z, Martin RM, Eeles R, PRACTICAL Consortium, CRUK GWAS Investigators, Richards JB (2013). An assessment of the shared allelic architecture between type II diabetes and prostate cancer. Cancer Epidemiol Biomarkers Prev, 22(8), 1473-5.
  73. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Kbel M, PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Rossing MA, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubiski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kjaer SK, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Hgdall CK, Hgdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Drst M, du Bois A, Drk T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA, Australian Ovarian Cancer Study Group, Australian Cancer Study, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Pearce CL (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun, 4, 1628.
  74. Scholand MB, Coon H, Wolff R, Cannon-Albright L (2013). Use of a genealogical database demonstrates heritability of pulmonary fibrosis. Lung, 191(5), 475-81.
  75. Kauwe JS, Ridge PG, Foster NL, Cannon-Albright LA (2013). Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study. PLoS One, 8(10), e77087.
  76. Yates WR, Johnson C, McKee P, Cannon-Albright LA (2013). Genetic analysis of low BMI phenotype in the Utah Population Database. PLoS One, 8(12), e80287.
  77. Nelson Q, Agarwal N, Stephenson R, Cannon-Albright LA (2013). A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer. Front Genet, 4, 152.
  78. Lin WY, Brock IW, Connley D, Cramp H, Tucker R, Slate J, Reed MW, Balasubramanian SP, Cannon-Albright LA, Camp NJ, Cox A (2013). Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PLoS One, 8(7), e68578.
  79. Hawkes JE, Campbell J, Garvin D, Cannon-Albright L, Cassidy P, Leachman SA (2013). Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi. Front Oncol, 3, 160.
  80. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dork T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, OBrien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Roder MA, Frikke-Schmidt R, Bojesen SE, FitzGerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA (2013). A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet, 22(2), 408-15.
  81. Hawkes JE, Cassidy PB, Manga P, Boissy RE, Goldgar D, Cannon-Albright L, Florell SR, Leachman SA (2013). Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. J Dermatol Sci, 69(1), 30-7.
  82. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC, Kote-Jarai Z, Easton DF (2013). Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet, 45(4), 385-91, 391e1-2.
  83. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russell R, Dunning AM, Luccarini C, Dennis J, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle A, Clements JA, Teixeira MR, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dicks E, Baynes C, Conroy D, Bojesen SE, Kaaks R, Vincent D, Bacot F, Tessier DC, Easton DF, Eeles RA (2013). Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet, 22(12), 2520-8.
  84. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF Jr, de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2013). Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet, 45(8), 868-76.
  85. Lee JP, Hopf HW, Cannon-Albright LA (2013). Empiric evidence for a genetic contribution to predisposition to surgical site infection. Wound Repair Regen, 21(2), 211-5.
  86. Cannon-Albright LA, Dintelman S, Maness T, Backus S, Thomas A, Meyer LJ (2013). Creation of a national resource with linked genealogy and phenotypic data: the Veterans Genealogy Project. Genet Med, 15(7), 541-7.
  87. Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Gronberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB (2013). HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet, 132(1), 5-14.
  88. Cannon-Albright LA, Teerlink CC, Farnham JM, Thomas AW, Zone JJ, Leachman SA (2013). Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21. J Invest Dermatol, 133(1), 128-34.
  89. Norton PA, Allen-Brady K, Cannon-Albright LA (2013). The familiality of pelvic organ prolapse in the Utah Population Database. Int Urogynecol J, 24(3), 413-8.
  90. Calvert GT, Randall RL, Jones KB, Cannon-Albright L, Lessnick S, Schiffman JD (2012). At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma, 2012, 152382.
  91. Cai Z, Thomas A, Teerlink C, Farnham JM, Cannon-Albright LA, Camp NJ (2012). Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees. BMC Genomics, 13(1), 676.
  92. Kareus SA, Figueroa KP, Cannon-Albright LA, Pulst SM (2012). Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch Neurol, 69(12), 1572-7.
  93. Samadder NJ, Cannon-Albright LA, Burt RW (2012). The impact of family history on the risk of colorectal neoplasia: don't change the guidelines just yet! Dig Dis Sci, 57(12), 3047-9.
  94. Albright F, Teerlink C, Werner TL, Cannon-Albright LA (2012). Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer, 12, 138.
  95. Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Stanford JL, Karyadi DM, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Lange EM, Cooney KA, Tammela TL, Schleutker J, Maier C, Bochum S, Hoegel J, Gronberg H, Wiklund F, Emanuelsson M, Cancel-Tassin G, Valeri A, Cussenot O, Isaacs WB (2012). Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet, 13(1), 46.
  96. Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Gronberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J (2012). Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet, 131(7), 1095-103.
  97. Teerlink CC, Albright FS, Lins L, Cannon-Albright LA (2012). A comprehensive survey of cancer risks in extended families. Genet Med, 14(1), 107-14.
  98. Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A (2012). Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev, 21(1), 176-81.
  99. Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Gronberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, FitzGerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB (2012). Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate, 72(4), 410-26.
  100. Teerlink C, Farnham J, Allen-Brady K, Camp NJ, Thomas A, Leachman S, Cannon-Albright L (2012). A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q. Hum Genet, 131(1), 77-85.
  101. Patel AA, Spiker WR, Daubs M, Brodke DS, Cannon-Albright LA (2012). Evidence of an inherited predisposition for cervical spondylotic myelopathy. Spine (Phila Pa 1976), 37(1), 26-9.
  102. Allen-Brady K, Cannon-Albright L, Farnham JM, Teerlink C, Vierhout ME, van Kempen LC, Kluivers KB, Norton PA (2011). Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol, 118(6), 1345-53.
  103. Carlquist JF, McKinney JT, Horne BD, Camp NJ, Cannon-Albright L, Muhlestein JB, Hopkins P, Clarke JL, Mower CP, Park JJ, Nicholas ZP, Huntinghouse JA, Anderson JL (2011). Common Variants in 6 Lipid-Related Genes Discovered by High-Resolution DNA Melting Analysis and Their Association with Plasma Lipids.LID - 2155-9880-2-138 [pii]. J Clin Exp Cardiolog, 2(138).
  104. Allen-Brady K, Farnham J, Cannon-Albright L (2011). Strategies for selection of subjects for sequencing after detection of a linkage peak. BMC Proc, 5 Suppl 9(Suppl 9 Genetic Analysis Workshop 17: Unraveling Human Exome DataS Ghosh, H Bickeboller, J Bailey, JE Bailey-Wilson, R Cantor, W Daw, AL DeStefano, CD Engelman, A Hinrichs, J Houwing-Duistermaat, IR Konig, J Kent Jr., N Pankratz, A Paterson, E Pugh, Y Su), S77.
  105. Diedrich KT, Roberts JA, Schmidt RH, Albright LA, Yetman AT, Parker DL (2011). Medical record and imaging evaluation to identify arterial tortuosity phenotype in populations at risk for intracranial aneurysms. AMIA Annu Symp Proc, 2011, 295-304.
  106. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril MF, Azizi E, Bakker B, Bergman W, Bianchi-Scarra G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Corda E, Cust AE, Debniak T, Duffy D, Dunning AM, Easton DF, Friedman E, Galan P, Ghiorzo P, Giles GG, Hansson J, Hocevar M, Hoiom V, Hopper JL, Ingvar C, Janssen B, Jenkins MA, Jonsson G, Kefford RF, Landi G, Landi MT, Lang J, Lubinski J, Mackie R, Malvehy J, Martin NG, Molven A, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Pastorino L, Puig S, Puig-Butille JA, Randerson-Moor J, Snowden H, Tuominen R, Van Belle P, van der Stoep N, Whiteman DC, Zelenika D, Han J, Fang S, Lee JE, Wei Q, Lathrop GM, Gillanders EM, Brown KM, Goldstein AM, Kanetsky PA, Mann GJ, Macgregor S, Elder DE, Amos CI, Hayward NK, Gruis NA, Demenais F, Bishop JA, Bishop DT (2011). Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet, 43(11), 1108-13.
  107. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Stanford JL, Ostrander EA, Sorensen KD, Dork T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Gardiner RA, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang HW, Lu YJ, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, OBrien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English DR, Wahlfors T, Tammela TL, Klarskov P, Nordestgaard BG, Roder MA, Tybjaerg-Hansen A, Bojesen SE, Travis R, Canzian F, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, Fitzgerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin HY, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V, Easton DF, Eeles RA (2011). Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet, 43(8), 785-91.
  108. Jones KB, Haldar M, Schiffman JD, Cannon-Albright L, Lessnick SL, Sharma S, Capecchi MR, Randall RL (2011). Of mice and men: opportunities to use genetically engineered mouse models of synovial sarcoma for preclinical cancer therapeutic evaluation. Cancer Control, 18(3), 196-203.
  109. Cai Z, Camp NJ, Cannon-Albright L, Thomas A (2011). Identification of regions of positive selection using Shared Genomic Segment analysis. Eur J Hum Genet, 19(6), 667-71.
  110. Cannon-Albright LA, Cooper KG, Georgelas A, Bernard PS (2011). High quality and quantity Genome-wide germline genotypes from FFPE normal tissue. BMC Res Notes, 4(1), 159.
  111. Albright F, Light K, Light A, Bateman L, Cannon-Albright LA (2011). Evidence for a heritable predisposition to Chronic Fatigue Syndrome. BMC Neurol, 11(1), 62.
  112. Lin WY, Camp NJ, Cannon-Albright LA, Allen-Brady K, Balasubramanian S, Reed MW, Hopper JL, Apicella C, Giles GG, Southey MC, Milne RL, Arias-Perez JI, Menendez-Rodriguez P, Benitez J, Grundmann M, Dubrowinskaja N, Park-Simon TW, Dork T, Garcia-Closas M, Figueroa J, Sherman M, Lissowska J, Easton DF, Dunning AM, Rajaraman P, Sigurdson AJ, Doody MM, Linet MS, Pharoah PD, Schmidt MK, Cox A (2011). A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet, 48(7), 477-84.
  113. Taylor DP, Cannon-Albright LA, Sweeney C, Williams MS, Haug PJ, Mitchell JA, Burt RW (2011). Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med, 13(8), 737-43.
  114. Seger HM, Soisson AP, Dodson MK, Rowe KG, Cannon-Albright LA (2011). Familial clustering of endometrial cancer in a well-defined population. Gynecol Oncol, 122(1), 75-8.
  115. Patel AA, Spiker WR, Daubs M, Brodke D, Cannon-Albright LA (2011). Evidence for an inherited predisposition to lumbar disc disease. J Bone Joint Surg Am, 93(3), 225-9.
  116. Taylor DP, Stoddard GJ, Burt RW, Williams MS, Mitchell JA, Haug PJ, Cannon-Albright LA (2011). How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med, 13(5), 385-91.
  117. Jones KB, Schiffman JD, Kohlmann W, Randall RL, Lessnick SL, Cannon-Albright LA (2011). Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer Epidemiol Biomarkers Prev, 20(5), 751-7.
  118. Couldwell WT, Cannon-Albright L (2010). A heritable predisposition to pituitary tumors. Pituitary, 13(2), 130-7.
  119. Randall RL, Lessnick SL, Jones KB, Gouw LG, Cummings JE, Cannon-Albright L, Schiffman JD (2010). Is There a Predisposition Gene for Ewing's Sarcoma? J Oncol, 2010, 397632.
  120. Shirts BH, Burt RW, Mulvihill SJ, Cannon-Albright LA (2010). A population-based description of familial clustering of pancreatic cancer. Clin Gastroenterol Hepatol, 8(9), 812-6.
  121. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon-Albright LA, Mower CP, Park JJ, Clarke JL, Nicholas ZP, McKinney JT, Carlquist JF (2010). Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J, 160(2), 250-256.e3.
  122. Niazi TN, Cannon-Albright LA, Couldwell WT (2010). Utah Population Database: a tool to study the hereditary element of nonsyndromic neurosurgical diseases. Neurosurg Focus, 28(1), E1.
  123. Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Gronberg H, Wiklund F, Emanuelsson M, Farnham JM, Cannon-Albright LA, Camp NJ (2010). Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate, 70(7), 735-44.
  124. Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA (2010). Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology, 138(3), 877-85.
  125. Painter JN, Willemsen G, Nyholt D, Hoekstra C, Duffy DL, Henders AK, Wallace L, Healey S, Cannon-Albright LA, Skolnick M, Martin NG, Boomsma DI and Montgomery GW (2010). A genome wide linkage scan for dizygotic twinning in 525 families of mothers of dizygotic twins. Hum Reprod, 25(6), 1569-80.
  126. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL (2009). Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis, 15(1), 44-8.
  127. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dork T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, OBrien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G, Easton DF (2009). Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet, 41(10), 1116-21.
  128. Teerlink CC, Camp NJ, Bansal A, Crapo R, Hughes D, Kort E, Rowe K, Cannon-Albright LA (2009). Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource. Eur J Hum Genet, 17(5), 636-43.
  129. Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MW, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, Allen-Brady K, Camp NJ, Cox A (2009). A breast cancer risk haplotype in the caspase-8 gene. Cancer Res, 69(7), 2724-8.
  130. Camp NJ, Farnham JM, Wong J, Christensen GB, Thomas A, Cannon-Albright LA (2009). Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study. Cancer Epidemiol Biomarkers Prev, 18(4), 1290-4.
  131. Allen-Brady K, Norton PA, Farnham JM, Teerlink C, Cannon-Albright LA (2009). Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet, 84(5), 678-82.
  132. Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright LA (2009). Evidence for an inherited predisposition contributing to the risk for rotator cuff disease. J Bone Joint Surg Am, 91(5), 1136-42.
  133. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kampjarvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schurmann P, Dork T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Vant Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M (2009). Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev, 18(5), 1610-6.
  134. Allen-Brady K, Farnham JM, Camp NJ, Karlins E, Ostrander EA, Cannon-Albright LA (2009). No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees. BMC Res Notes, 2, 94.
  135. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ (2009). Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 18(9), 2476-84.
  136. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarr G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin-A-Woeng T, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Hiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubinski J, Mackie R, Malvehy J, Mann GJ, Martin NG, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Puig S, Weiss M, van Workum W, Zelenika D, Brown KM, Goldstein AM, Gillanders EM, Boland A, Galan P, Elder DE, Gruis NA, Hayward NK, Lathrop GM, Barrett JH, Bishop JA (2009). Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet, 41(8), 920-5.
  137. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Bishop DT, Cox A, Camp NJ, Colorectal Cancer Study Group (2009). Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev, 18(2), 616-21.
  138. Camp NJ, Werner TL, Cannon-Albright LA (2008). Familial myeloma. N Engl J Med, 359(16), 1734-5; author reply 1735.
  139. Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D, Factors Associated with Childhood Tumours FACT Collaboration, Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N (2008). Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet, 40(11), 1329-34.
  140. Blumenthal DT, Cannon-Albright LA (2008). Familiality in brain tumors. Neurology, 71(13), 1015-20.
  141. Rausch T, Thomas A, Camp NJ, Cannon-Albright LA, Facelli JC (2008). A parallel genetic algorithm to discover patterns in genetic markers that indicate predisposition to multifactorial disease. Comput Biol Med, 38(7), 826-36.
  142. Cannon-Albright LA (2008). Detection of aneurysms. J Neurosurg, 108(6), 1130-1.
  143. Florell SR, Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2008). Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. J Invest Dermatol, 128(8), 2122-5.
  144. Cannon Albright LA (2008). Utah family-based analysis: past, present and future. Hum Hered, 65(4), 209-20.
  145. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2008). Shared genomic segment analysis. Mapping disease predisposition genes in extended pedigrees using SNP genotype assays. Ann Hum Genet, 72(Pt 2), 279-87.
  146. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008). Evidence for a heritable predisposition to death due to influenza. J Infect Dis, 197(1), 18-24.
  147. Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Lund Melanoma Study Group, Melanoma Genetics Consortium GenoMEL (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet, 44(2), 99-106.
  148. Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA (2007). Population-Based Assessment of Non-Melanoma Cancer Risk in Relatives of Cutaneous Melanoma Probands. J Invest Dermatol, 127(1), 183-8.
  149. Christensen GB, Cannon-Albright LA, Thomas A, Camp NJ (2007). Extracting Disease Risk Profiles from Expression Data for Linkage Analysis: Application to Prostate Cancer. BMC Proc, Suppl(1), S82.
  150. Eliason MJ, Hansen CB, Hart M, Porter-Gill P, Chen W, Sturm RA, Bowen G, Florell SR, Harris RM, Cannon-Albright LA, Swinyer L, Leachman SA (2007). Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol, 143(11), 1409-12.
  151. Weires MB, Tausch B, Haug PJ, Edwards CQ, Wetter T, Cannon-Albright LA (2007). Familiality of diabetes mellitus. Exp Clin Endocrinol Diabetes, 115(10), 634-40.
  152. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2007). Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees. Prostate, 67(6), 605-13.
  153. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Gronberg H, Wiklund F, Emanuelsson M, Isaacs WB (2007). Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet, 16(11), 1271-8.
  154. Maul JS, Burt RW, Cannon-Albright LA (2007). A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol, 5(9), 1080-4.
  155. Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2007). Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb. Prostate, 67(13), 1456-64.
  156. Teerlink CC, Hegewald MJ, Cannon-Albright LA (2007). A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med, 176(9), 865-70.
  157. Goldfarb-Rumyantzev AS, Cheung AK, Habib AN, Wang BJ, Lin SJ, Baird BC, Naiman N, Cannon-Albright L (2006). A population-based assessment of the familial component of chronic kidney disease mortality. Am J Nephrol, 26(2), 142-8.
  158. Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Melanoma Genetics Consortium GenoMEL (2006). High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res, 66(20), 9818-28.
  159. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, Bishop DT, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh CL, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TL, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA (2006). Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet, 120(4), 471-85.
  160. Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA (2006). Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol, 126(3), 660-6.
  161. Horne BD, Carlquist JF, Cannon-Albright LA, Muhlestein JB, McKinney JT, Kolek MJ, Clarke JL, Anderson JL, Camp NJ (2006). High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann Hum Genet, 70(Pt 4), 524-34.
  162. Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ (2006). A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 15(7), 1306-10.
  163. Maul JS, Warner NR, Kuwada SK, Burt RW, Cannon-Albright LA (2006). Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol, 101(7), 1591-6.
  164. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2006). Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J, 152(2), 305-11.
  165. Camp NJ, Farnham JM, Cannon-Albright LA (2006). Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res, 66(20), 10205-12.
  166. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D, ACTANE Consortium (2005). A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet, 77(2), 219-29.
  167. Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM, Grossman D, Samlowski WE, Zone JJ, Brinton JP, Leachman SA (2005). Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. J Invest Dermatol, 125(6), 1310-2.
  168. Camp NJ, Cannon-Albright LA (2005). Dissecting the genetic etiology of major depressive disorder using linkage analysis. Trends Mol Med, 11(3), 138-144.
  169. Camp NJ, Lowry MR, Richards RL, Plenk AM, Carter C, Hensel CH, Abkevich V, Skolnick MH, Shattuck D, Rowe KG, Hughes DC, Cannon-Albright LA (2005). Genome-wide Linkage Analyses of Extended Utah Pedigrees Identifies Loci that Influence Recurrent, Early-Onset Major Depression and Anxiety Disorders. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, May 5:135(1), 85-93.
  170. Schaid DJ, Chang BL, Cannon-Albright LA, and the International Consortium for Prostate cancer Genetics (2005). Description of the International Consortium for Prostate Cancer Genetics, and Failure to Replicate Linkage of Hereditary Prostate Cancer to 20q13. Prostate, 63(3), 276-90.
  171. Berthelemy-Okazaki N, Zhao Y, Yang Z, Camp NJ, Farnham J, Parker D, Tsuruda J, Macdonald J, Zhang K, Cannon-Albright LA (2005). Examination of ELN as a candidate gene in the Utah intracranial aneurysm pedigrees. Stroke, 36(6), 1283-4.
  172. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005). Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer, 117(4), 655-61.
  173. Camp NJ, Farnham JM, Cannon Albright LA (2005). Genomic search for prostate cancer predisposition loci in Utah pedigrees. Prostate, 65(4), 365-74.
  174. Cannon-Albright LA, Farnham JM, Thomas A, Camp NJ (2005). Identification and study of Utah pseudo-isolate populations-prospects for gene identification. Am J Med Genet A, 137A(3), 269-75.
  175. Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, Wiggins C, Noyes RD, Tsodikov A, Cannon-Albright LA, Zone JJ, Samlowski WE, Leachman SA (2005). Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol, 23(28), 7168-77.
  176. Cannon-Albright LA, Schwab A, Camp NJ, Farnham JS, Thomas A (2005). Population-based Risk Assessment for Other Cancers in Relatives of Hereditary Prostate Cancer (HPC) Cases. Prostate, 64(4), 347-355.
  177. Camp NJ, Swensen J, Horne BD, Farnham JM, Thomas A, Cannon-Albright LA, Tavtigian SV (2005). Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet Epidemiol, 28(3), 232-43.
  178. Farnham JM, Camp NJ, Swensen J, Tavtigian SV, Cannon-Albright LA (2004). Confirmation of the HPCX cancer predisposition locus in large Utah prostate cancer pedigrees. Hum Genet, 116(3), 179-85.
  179. Farnham JM, Camp NJ, Neuhausen SL, Tsuruda J, Parker D, MacDonald J, Cannon-Albright LA (2004). Confirmation of chromosome 7q11 locus for predisposition to intracranial aneurysm. Hum Genet, 114(3), 250-5.
  180. Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J, Cannon-Albright LA, Pershing LK, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2004). Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol, 123(3), 576-82.
  181. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2004). Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation, 110(19), 3143-8.
  182. Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, Plenk AM, Lowry MR, Richards RL, Carter C, Frech GC, Stone S, Rowe K, Chau CA, Cortado K, Hunt A, Luce K, ONeil G, Poarch J, Potter J, Poulsen GH, Saxton H, Bernat-Sestak M, Thompson V, Gutin A, Skolnick MH, Shattuck D, Cannon-Albright L (2003). Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet, 73(6), 1271-81.
  183. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG (2003). A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg, 99(4), 637-43.
  184. Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium (2002). Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst, Sep 18:94(18), 1358-1365.
  185. Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium (2002). Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev, 11, 329-336.
  186. Deffenbaugh AM, Frank TS, Hoffman M, Cannon-Albright L, Neuhausen SL (2002). Characterization of common BRCA1 and BRCA2 variants. Genet Test, 6(2), 119-21.
  187. Florell SR, Boucher KM, Holden JA, Meyer LJ, Samlowski WE, Cannon-Albright LA, Zone JJ, Leachman SA (2002). Failure to detect differences in proliferation status of nevi from CDKN2A mutation carriers and non-carriers. J Invest Dermatol, 118(2), 386-7.
  188. Gutin A, Abkevich V, Camp NJ, Farnham JM, Cannon-Albright L, Thomas A (2001). Allelic association in large pedigrees. Genet Epidemiol, 21 Suppl 1, S571-5.
  189. Abkevich V, Camp NJ, Gutin A, Farnham JM, Cannon-Albright L, Thomas A (2001). A robust multipoint linkage statistic (tlod) for mapping complex trait loci. Genet Epidemiol, 21 Suppl 1, S492-7.
  190. Camp NJ, Gutin A, Abkevich V, Farnham JM, Cannon-Albright L, Thomas A (2001). A new nonparametric linkage statistic for mapping both qualitative and quantitative trait loci. Genet Epidemiol, 21 Suppl 1, S461-6.
  191. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA (2001). A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet, 27(2), 172-80.
  192. Bansal A, Farnham JM, Crapo RO, Hughes DC, Jensen RL, Cannon-Albright LA (2001). A simple diagnostic index for asthma. Clin Exp Allergy, 31(5), 756-60.
  193. Xu J, and the International Consortium for Prostate Cancer Genetics ICPCG (2000). Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet, 66(3), 945-57.
  194. Bansal A, Hughes DC, Farnham JM, Bagi CM, ONeil G, Rowe K, Shakib JH, Wood GC, Wyckoff JA, Cannon-Albright LA (2000). Impact of correlated factors on bone density in individuals with a family history of osteoporosis. J Clin Densitom, 3(4), 333-8.
  195. Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium, Cannon-Albright LA (2000). Variation in cancer risks by mutation position in BRCA2 mutation carriers. Am J Hum Genet, 68(2), 410-9.
  196. Lewis C, Book L, Black J, Sawitzke A, Cannon-Albright LA, Zone J, Neuhausen S (2000). Celiac Disease and human leukocyte antigen genotype: Accuracy of diagnosis in self-diagnosed individuals, dosage effect and sibling risk. J Pediatr Gastroenterol Nutr, 31 (1), 22-27.
  197. Verhagen PC, Zhu XL, Rohr LR, Cannon-Albright LA, Tavtigian SV, Skolnick MH, Brothman AR (2000). Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers. Cancer Genet Cytogenet, 122(1), 43-8.
  198. Breast Cancer Linkage Consortium, Cannon-Albright LA (1999). Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst, 91, 1310-1316.
  199. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH (1999). Familial associations between cancer sites. Comput Biomed Res, 32(6), 517-29.
  200. Neuhausen SL, Farnham JM, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA (1999). Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees. Hum Mol Genet, 8(13), 2437-42.
  201. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL (1999). Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst, 91(17), 1475-9.
  202. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnetd, Bigon Y, Borg A, Hamann U, Haites N, Scotdt RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Hedman MZ, Breast Cancer Linkage Consortium (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62(3), 676-89.
  203. Gaffney DK, Brohet RM, Lewis CM, Holden JA, Buys SS, Neuhausen SL, Steele L, Avizonis V, Stewart JR, Cannon-Albright LA (1998). Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol, 47(2), 129-36.
  204. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D (1998). Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet, 62(6), 1381-8.
  205. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH-F, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright LA, Steele L, Offit K, Gilewski T, Norton L, Brown K, Schultz C, Hampel H, Schluger A, Giulotto E, Zoli W, Raviaoli A, Nevanlinna NH, Pyrhonen S, Rowley P, oader s, Osborne MP, Daly M, Tepler I, Weinstein PL, Scalia JL, Michaelson R, Scott RJ, Radice P, Pierotti MA, Garber JE, Isaacs C, Peshkin B, Lippman ME, Dosik MH, Caligo MA, Greenstein RM, Pilarski R, Weber B, Burgemeister R, Frank TS, Skolnick MH, Thomas A (1997). BRCA1 sequence analysis in women in high risk for susceptibility mutations. JAMA, 278, 1242-1250.
  206. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, Neuhausen SL, Ford D, Wooster R, Cannon-Albright LA, Stratton MR, Goldgar DE (1997). Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet, 61(1), 120-8.
  207. Swensen J, Lewis CM, Cannon-Albright LA (1997). Identification of a one-base germline deletion (codon 888 del C) and an intron splice acceptor site polymorphism in hMSH2. Hum Mutat, 10(1), 80-1.
  208. Neuhausen SL, Skolnick MH, Cannon-Albright L (1997). Familial prostate cancer studies in Utah. Br J Urol, 79 Suppl 1, 15-20.
  209. Lewis CM, Neuhausen SL, Daley D, Black FJ, Swensen J, Burt RW, Cannon-Albright LA, Skolnick MH (1996). Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res, 56(6), 1382-8.
  210. Meyer LJ, Piepkorn M, Goldgar DE, Lewis CM, Cannon-Albright LA, Zone JJ, Skolnick MH (1996). Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. J Am Acad Dermatol, 34(4), 618-25.
  211. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet, 12(3), 333-7.
  212. Cannon-Albright LA, Skolnick MH (1996). The genetics of familial breast cancer. Semin Oncol, 23(Suppl 2), 1-5.
  213. Couch FJ, Rommens JM, Neuhausen SL, Belanger C, Dumont M, Abel K, Bell R, Berry S, Bogden R, Cannon-Albright L, Farid L, Frye C, Hattier T, Janecki T, Jiang P, Kehrer R, Leblanc JF, McArthur-Morrison J, Meney D, Miki Y, Peng Y, Samson C, Schroeder M, Snyder SC, Simard J, et al (1996). Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics, 36(1), 86-99.
  214. Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA (1996). Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet, 12(3), 309-11.
  215. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar DE (1996). Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet, 58(2), 271-80.
  216. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright LA, Kamb A (1995). Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene, 11, 987-991.
  217. Cannon-Albright LA, Eeles R (1995). Progress in Prostate Cancer. Nat Genet, 9(4), 336-338.
  218. Narod SA, Goldgar D, Cannon-Albright LA, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H (1995). Risk modifiers in carriers of BRCA1 mutations. Int J Cancer, 64 (6), 394-398.
  219. Burt RW, DiSario JA, Cannon-Albright LA (1995). Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med, 46, 371-79.
  220. Neuhausen SL, Swensen JJ, Miki Y, Liu Q, Tavtigian S, Shattuck-Eidens D, Kamb A, Hobbs MR, Gingrich J, Shizuya H, Him U-J, Cochran C, Futreal PA, Wiseman RW, Lynch HT, Tonin P, Narod S, Cannon-Albright L, Skolnick MH, Goldgar D (1994). A P1-based physical map of the BRCA1 region from D17S776 to D17S78. Hum Mol Genet, 3(11), 1919-1926.
  221. Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir G, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis C, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR (1994). Localization of a breast cancer susceptibility gene (BRCA2) to chromosome 13q12-13. Science, 265, 2088-2090.
  222. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gris NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet, 8(1), 23-6.
  223. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright LA, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994). A Strong Candidate for the Breast and Ovarian Cancer susceptibility Gene BRCA 1. Science, 266, 66-71.
  224. Stratton MR, Ford D, Neuhausen S, Seal S, Wooster R, Friedman LS, King M-C, Egilsson V, Devilee P, McMarus R, Daly PA, Smith E, Ponder BAJ, Pelo J, Cannon-Albright LA, Easton D, Goldgar D (1994). Familial male breast cancer is not linked to BRCA1 locus on chromosome 17q. Nat Genet, 7(1), 103-7.
  225. Goldgar DE, Fields P, Lewis CM, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH (1994). A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst, 86(3), 200-9.
  226. Cannon-Albright LA, Bishop DT, Samowitz W, DiSario JA, Lee R, Burt RW (1994). Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol, 89(6), 827-31.
  227. Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWhorter WP, Jost M, Harrison D, Anderson DE, Zone JJ, Skolnick MH (1994). Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res, 54(23), 6041-4.
  228. Skolnick MH, Cannon-Albright LA, Kamb A (1994). Genetic predisposition to melanoma. Eur J Cancer, 30A(13), 1991-5.
  229. Cannon-Albright LA, Goldgar DE, Neuhausen S, Gruis NA, Anderson DE, Lewis CM, Jost M, Tran TD, Nguyen K, Kamb A, Weaver-Feldhaus J, Meyer LJ, Zone JJ, Skolnick MH (1994). Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics, 23(1), 265-8.
  230. Piepkorn MW, Barnhill RL, Cannon-Albright LA, Elder DE, Goldgar DE, Lewis CM, Maize JC, Meyer LJ, Rabkin MS, Sagebiel RW, et al (1994). A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol, 30(5 Pt 1), 707-14.
  231. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH (1994). Familiality of cancer in Utah. Cancer Res, 54(9), 2378-85.
  232. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994). Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst, 86(21), 1600-8.
  233. Goldgar DE, Cannon-Albright LA, Oliphant A, Ward JH, Linker G, Swensen J, Tran TD, Fields P, Uharriet P, Skolnick MH (1993). Chromosome 17q linkage studies of 18 Utah breast cancer kindreds. Am J Hum Genet, 52(4), 743-8.
  234. Burt RW, Bishop DT, Cannon-Albright LA, Samowitz WS, Lee RL, Disario JA, Skolnick MH (1992). Population-genetics of colonic cancer. Cancer, 70, 1719-1722.
  235. Burt RW, Bishop DT, Cannon-Albright LA, Samowitz WS, Lee RL, Disario JA, Skolnick MH (1992). Hereditary aspects of colorectal adenomas. Cancer, 70, 1296-1299.
  236. Meyer LJ, Goldgar DE, Cannon-Albright LA, Piepkorn MW, Zone JJ, Risman MB, Skolnick MH (1992). Number, size, and histopathology of nevi in Utah kindreds. Cytogenet Cell Genet, 59(2-3), 167-9.
  237. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1992). Inheritance of nevus number and size in melanoma/DNS kindreds. Cytogenet Cell Genet, 59(2-3), 200-2.
  238. Skolnick MH, Cannon-Albright LA (1992). Genetic predisposition to breast cancer. Cancer, 70(6 Suppl), 1747-54.
  239. McWhorter WP, Hernandez AD, Meikle AW, Terreros DA, Smith JA Jr, Skolnick MH, Cannon-Albright LA, Eyre HJ (1992). A screening study of prostate cancer in high risk families. J Urol, 148(3), 826-8.
  240. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, et al (1992). Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science, 258(5085), 1148-52.
  241. Skolnick MH, Marshall CJ, McWhorter W, Goldgar D, Cannon-Albright LA, Ward JH, Eyre H (1991). Proliferative breast disease: Diagnosis and implications. Science, 253(5022), 915-916.
  242. Marshall CJ, Schumann GB, Ward JH, Riding JM, Cannon-Albright LA, Skolnick MH (1991). Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Am J Clin Pathol, 95:2, 157-165.
  243. Ahmed I, Piepkorn M, Goldgar DE, Cannon-Albright LA, Meyer LJ, Skolnick MH, Zone JJ (1991). HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups. J Cutan Pathol, 18(4), 257-60.
  244. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1991). Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst, 83(23), 1726-33.
  245. Cannon-Albright LA, Goldgar DE, Wright EC, Turco A, Jost M, Meyer LJ, Piepkorn M, Zone JJ, Skolnick MH (1990). Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36. Am J Hum Genet, 46(5), 912-8.
  246. Ward JH, Marshall CJ, Schumann GB, Hogle H, Cannon-Albright LA, McWhorter WP, Eyre HJ, Skolnick MH (1990). Detection of proliferative breast disease by four-quadrant, fine-needle aspiration. J Natl Cancer Inst, 82(11), 964-6.
  247. Skolnick MH, Cannon-Albright LA, Goldgar DE, Ward JH, Marshall CJ, Schumann GB, Hogle H, McWhorter WP, Wright EC, Tran TD, et al (1990). Inheritance of proliferative breast disease in breast cancer kindreds. Science, 250(4988), 1715-20.
  248. Piepkorn M, Meyer LJ, Goldgar D, Seuchter SA, Cannon-Albright LA, Skolnick MH, Zone JJ (1989). The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol, 20(3), 407-15.
  249. Cannon-Albright LA, Thomas TC, Bishop DT, Skolnick MH, Burt RW (1989). Characteristics of familial colon cancer in a large population data base. Cancer, 64(9), 1971-5.
  250. Atkin CL, Hasstedt SJ, Menlove L, Cannon-Albright LA, Kirschner N, Schwartz C, Nguyen K, Kinkel L, Bruns G, Skolnick MH (1988). Mapping of alport syndrome to the long arm of the X Chromosome. Am J Hum Genet, 42, 249-255.
  251. Meyer LJ, Piepkorn MA, Seuchter SA, Cannon-Albright LA, Bishop DT, Zone JJ, Skolnick MH (1988). Genetic and epidemiologic evaluation of dysplastic nevi. Pigment Cell Res, 1(Supple), 144-151.
  252. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW (1988). Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med, 319(9), 533-7.
  253. Burt RW, Bishop DT, Lee RG, Cannon-Albright LA, Skolnick MH (1988). Inheritance of colonic adenomatous polyps and colorectal cancer. Prog Clin Biol Res, 279, 189-94.
  254. Bishop DT, Cannon-Albright L, McLellan T, Gardner EJ, Skolnick MH (1988). Segregation and linkage analysis of nine Utah breast cancer pedigrees. Genet Epidemiol, 5(3), 151-69.
  255. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Kivlin J, Willard H, Nakamura Y, OConnell P, Leppert M, White R, Skolnick MH (1987). A genomic search for linkage of neurofibromatosis to RFLPs. J Med Genet, 24(9), 536-8.
  256. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Livlin J, Willard H, Nakamura Y, OConnell P, Leppert M, White R, Skolnick MH (1987). Gene for Von Recklinhausen neuro-fibramatosis is in the pericentromeric region of Chromosome 17. Science, 236, 1100-1102.
  257. Kivlin JD, Sanborn, GE, Wright E, Cannon L, Carey J (1987). Brief Clinical Report: Further linkage data on Norrie disease. Am J Med Genet, 26(3), 733-6.
  258. Bailey-Wilson JE, Cannon LA, King MC (1986). Genetic analysis of human breast cancer: A synthesis of contributions to GAW IV. Genet Epidemiol Suppl, 1, 15-35.
  259. King MC, Cannon LA, Bailey-Wilson JE (1986). Genetic analysis of human breast cancer: Literature review and description of family data in workshop. Genet Epidemiol Suppl, Suppl 1, 3-13.
  260. Cannon LA, Bishop DT, Skolnick MH (1986). Segregation and linkage analysis of breast cancer in the Dutch and Utah families. Genet Epidemiol Suppl, 1, 43-8.
  261. Bishop DT, Cannon LA, Chamberlin AR, Skolnick MH (1986). Strategies for efficient linkage analysis: example of Huntington's disease pedigrees. Genet Epidemiol Suppl, Suppl.(1), 217-22.
  262. Dietz JN, Robbins T, Cannon LA, Schwartz CE, Carey JC, Johnson JP, Kivlin J, Skolnick MH (1986). Linkage Analysis of Von Recklinghausen Neurofibromatosis: Chromosomes 4 and 19. Genet Epidemiol, 3(5), 313-21.
  263. Bishop DT, Cannon LA, Hasstedt SJ, Skolnick MH (1985). Genetic analysis workshop III: Multilocus linkage analysis using PAP. Genet Epidemiol, 2(2), 203-204.
  264. Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH (1985). Dominant inheritance of adenomatous polyps and colorectal cancer. N Engl J Med, 312, 1540-1544.
  265. Skolnick MH, Thompson EA, Bishop DT, Cannon LA (1984). Possible linkage of a breast cancer susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation. Genet Epidemiol, 1(4), 363-73.
  266. Bishop DT, Cannon LA, Hasstedt SH, Skolnick MH (1984). Genetic Analysis Workshop II: segregation and three-locus linkage analysis. Genet Epidemiol, 1(2), 161-5.
  267. Livingston G, Cannon L, Bishop DT, Johnson P, Fineman R (1983). Sisterchromatid exchange: variation by age, sex, smoking and breast cancer status. Cancer Genet Cytogenet, 9(3), 289-99.
  268. Cannon L, Bishop DT, Skolnick MH, Hunt S, Lyon JL, Smart C (1982). Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surveys, 1(1), 48-69.

Review

  1. Cannon-Albright LA, Kamb A, Skolnick M (1996). A review of inherited predisposition to melanoma. [Review]. Semin Oncol, 23(6), 667-72.
  2. Cannon-Albright LA, Bishop DT, Goldgar C, Skolnick MH (1991). Genetic predisposition to cancer. [Review]. Important Advances in Oncology, 39-55.

Book Chapter

  1. Singh R, Eeles RA, Cannon-Albright LA, Isaacs W (2004). Familial prostate cancer and its management. In Eeles RA, Easton DF, Ponder BAJ, Eng C (Eds.), Genetic Predisposition to Cancer (2nd, pp. 339-351). London.
  2. Neuhausen SL, Cannon-Albright LA (2000). Progress in the identification of prostate cancer genes. In New Perspectives in Prostate Cancer, 2nd Edition: (A. Bellegrun, R. Kirby, D. Newling, eds) ISIS Medical Media Ltd (pp. 55-64).
  3. Neuhausen SL, Skolnick MH, Cannon-Albright LA (1998). Genetic susceptibility to prostate cancer. In New Perspectives in Prostate Cancer. (A. Bellegrun, R. Kirby, T. Oliver, eds.) ISIS Medical Media Ltd (pp. 11-19).
  4. Neuhausen SL, Skolnick MH, Cannon-Albright LA (1997). Familial prostate cancer studies in Utah. In Seminars in Oncology (79, pp. 15-20). London: British Journal of Urology.
  5. Cannon-Albright LA, Skolnick MH (1996). The genetics of familial breast cancer. In Yarbro J, Bornstein R, Mastrangelo M (Eds.), Seminars in Oncology (23, pp. 667-672). WB Saunders Company.
  6. Goldgar DE, Steel L, Neuhausen S, Lewis CM, Cannon-Albright L, Skolnick M (1996). Breast and ovarian Cancer in Utah kindreds with three BRCA1 mutations. In Ovarian Cancer 4, (HF. Sharp, T. Blackett, R. Leake, J. Berek, eds) Chapman & Hall (pp. 49-59).
  7. Eeles RA, Cannon-Albright LA (1996). Familial prostate cancer and its management. In Eeles RA, Easton DF, Ponder BAJ (Eds.), Genetic Predisposition to Cancer (pp. 320-330). London: Chapman & Hall.
  8. Skolnick MH, Cannon-Albright LA (1996). Penetrance, expressivity, and heterogeneity of melanoma susceptibility: A case study of dominant cancer susceptibility genes. In Frontiers in endocrinology: where phenotype does not match genotype (16).
  9. Goldgar DE, Rowe K, Lewis CM, McDonald M, Gholami K, Cannon-Albright LA, Skolnick M (1994). Genetic Epidemiology of familial ovarian cancer in Utah. In Proceedings of the HHMT Forum on Ovarian Cancer, (F. Sharp, T Blackett, eds). Chapman & Hall (pp. 13-21).
  10. Burt RW, Cannon-Albright LA, Bishop DT, Samowitz WS, DiSario JA, Skolnick MH (1993). Familial factors in sporadic adenomas and colorectal cancer. In Watne AL (Ed.), Problems in General Surgery (10, pp. 688-694). JB Lippincott Company.
  11. Lewis CM, Goldgar DE, Cannon-Albright LA, Skolnick MH (1993). Genetic analysis of cancer and precursor lesions. In Precancerous Lesions: A Multidisciplinary Approach. (Marks PA, Turler H, Weil R, eds.). Christengraf Press (pp. 69-77).
  12. Cannon-Albright LA, Bishop DT, Goldgar C, Skolnick MH (1991). Genetic predisposition to cancer. In Important Advances in Oncology, (VT Devita, JR, S. Hellman, SA Rosenberg, eds). Philadelphia: J. B. Lippencott Co (pp. 39-55).
  13. Bishop DT, Cannon-Albright LA, Skolnick MH (1991). Linkage mapping of cancer susceptibility genes. In Recent Progress in the Genetic Epidemiology of Cancer. (H. T. Lynch and P. Tautu, eds). Springer-Verlag Berlin Heidelberg (pp. 36-48).
  14. Cannon-Albright LA, Bishop DT, Goldgar DE, Skolnick MH (1991). Genetic epidemiology of cancer and predisposing lesions. In Recent Progress in the Genetic Epidemiology of Cancer. (H. T. Lynch and P. Tautu, eds). Springer-Verlag Berlin Heidelberg (pp. 57-65).
  15. Bishop DT, Cannon-Albright LA, Burt RW, Skolnick MH (1990). The inheritance of susceptibility to polyps. In Hereditary Cancer and Preventive Surgery, (W. Weber, UT Laffer, M Durig, eds). S. Karger, Basel Switzerland (pp. 39-45).
  16. Bishop DT, Cannon-Albright LA, Burt RW, Skolnick MH (1990). Pedigree analysis of susceptibility to colonic adenomas. In Hereditary Colorectal Cancer, Proceedings of the 4th International Symposium on Colorectal Cancer. (J Utsunomiya, HT Lynch, eds ). Tokyo: Springer-Verlag Tokyo, Incorporated (pp. 423-430).
  17. Burt RW, Cannon-Albright LA, Bishop DT, Skolnick MH (1989). Inheritance of susceptibility to colonic adenomatous polyps. In Cancer Cells: Molecular Diagnostics of Human Cancer, Cold Spring Harbor (pp. 249-251).
  18. Burt RW, Bishop DT, Lee RG, Cannon-Albright LA, Skolnick MH (1988). Inheritance of colonic adenomatous polyps and colorectal cancer. In Basic and Clinical Perspectives of Colorectal Polyps and Cancer, (R. Burt, G. Steele, S. Winawer, Eds.). CRC Press (pp. 189-194).
  19. Cannon LA, Skolnick MH, Bishop DT (1985). Restriction fragment length polymorphisms and cancer. In Familial Cancer (HJ Muller, W Weber, eds), 1st Int Res Conf, Basel: Karger (pp. 248-251).
  20. Burt RW, Dowdle M, Cannon LA, Bishop DT, Lee RG, Skolnick M (1984). The colonic adenomatous polyp as a marker for inherited colon cancer. In Markers of Colonic Cell Differentiation, (SR Wolman, AJ Mastromarino eds.), Progress in Cancer Research and Therapy (29, pp. 395-402).

Conference Proceedings

  1. Krikov S, Price R, Allen K, Cannon-Albright L, Facelli JC (2008). Enabling GeneHunter as a Grid Service: A Case Study for Implementing Analytical Services for Biomedical Grids. AMIA Annu Symp Proc. 2008 Nov. 6, AMIA Annu Symp Proc., 1014.
  2. Cannon-Albright LA (2006). Computerized genealogies linked to medical histories for research and clinical care--a national view. AMIA Annu Symp Proc, (2006), 1161-2.

Letter

  1. Camp NJ, Werner TL, Cannon-Albright LA (2008). Response to Lynch et al 'Familial Myeloma' [Letter to the editor]. N Engl J Med, 359(16), 1734-5.

Abstract

  1. Patel AA, Spiker WR, Sofianos DA, Daubs M, Brodke DS, Cannon-Albright LA (2011). Evidence of an Inherited Predisposition for Cervical Spondylosis with Myelopathy [Abstract]. Evidence & Technology Spine Summit, February 2 - 5th, Park City, UT, USA.
  2. Kareus S, Cannon-Albright LA (2011). Parkinson's Disease and Prostate Cancer: Insights Using the Utah Population Data Base [Abstract]. 63rd American Academy of Neurology Annual Meeting, April 9 - 16, Hawaii Convention Center, Honolulu, Hawaii.
  3. Kareus S, Cannon-Albright LA (2011). Relative Risk for Melanoma and Lung Cancer in the Parkinson 's Disease Population and Their Relatives Using the Utah Population Data Base [Abstract]. 63rd American Academy of Neurology Annual Meeting, April 9 - 16, Hawaii Convention Center, Honolulu, Hawaii.
  4. Spiker WR, Patel AA, Brodke DS, Daubs M, Cannon-Albright LA (2011). Evidence of an Inherited Predisposition for Spinal Cord Tumors [Abstract]. Evidence & Technology Spine Summit, February 2 - 5th Park City, UT, USA.
  5. Allen-Brady K, Cannon-Albright L, Baker J, Norton P (2011). Population-based Description of Familial Clustering in Overactive Bladder [Abstract]. Society of Urodynamics and Female Urology, Phoenix, AZ.
  6. Cannon-Albright L (2011). Genome-wide Germline Genotypes from Normal Tissue Stored in FFPE Samples [Abstract]. ISBER 2011 Annual Meeting & Exhibits, May 15-18, 2011, Arlington, VA (Washington, DC), USA.
  7. Wang W, Cannon-Albright LA, Tishler P (2010). Studies on the Familial Aggregation of Age at Diagnosis of Prostate Cancer: The Utah Population Database [Abstract]. International Genetic Epidemiology Society (IGES), October 10-12, Boston, MA, USA.
  8. Teerlink CC, Farnham JM, Allen-Brady K, Camp N, Horne B, Cannon-Albright LA (2010). Using Publically Available Control Data for GWAS – A Simple Strategy for Genetic Matching [Abstract]. International Genetic Epidemiology Society (IGES), October 10-12, Boston, MA, USA.
  9. Norton P, Allen-Brady K, Cannon-Albright LA (2010). Genetic Determinants of Stress Urinary Incontinence in Women [Abstract]. International Continence Society (ICS), August 23-27, Toronto, Canada.
  10. Norton P, Allen-Brady K, Cannon-Albright LA (2010). Genetic Determinants of Stress Urinary Incontinence in Women [Abstract]. Society for Urodynamics and Female Urology (SUFU), February, St. Petersburg, Florida.
  11. Cannon-Albright LA, Leachman SA (2010). Melanoma Cases with Multiple Independent Primary Melanomas Show the Strongest Evidence for a Heritable Predisposition [Abstract]. SMR Meeting, Sydney, Australia.
  12. Wang W, Cannon-Albright LA, Tishler PV (2010). Familial Aggregation of Age at Diagnosis of Prostate Cancer [Abstract]. International Genetic Epidemiology Society (IGES), October 10-12, Boston, MA, USA,Genetic Epidemiology, 34, 973.
  13. Norton P, Allen-Brady K, Cannon-Albright L (2010). Significant genome-wide association analysis in pelvic organ prolapse [Abstract]. 31st American Urogynecologic Society (AUGS) Meeting, September 30-October 2, Long Beach, CA USA,.
  14. Majersik JJ, Cannon-Albright LA (2010). Evidence for a Heritable Contribution to Death from Ischemic Stroke [Abstract]. International Stroke Genetics Consortium, Cincinnati, OH, January 7-8th, 2010.
  15. Majersik JJ, Cannon-Albright LA (2010). Evidence for a Heritable Contribution to Death from Ischemic Stroke [Abstract]. American Academy of Neurology Annual Meeting, Toronto, Ontario, April 10–17th, 2010.
  16. Lee J, Hopf HW, Cannon-Albright LA (2010). Familial Association with Surgical Site Infection in a Large Population Database [Abstract]. The World Healing Society Meeting, Orlando, Florida, April 17-20th, 2010.
  17. Moore HM, Soisson AP, Dodson MK, Rowe KG, Cannon-Albright LA (2010). Familial Clustering of Endothermal Cancer in a Well-Defined Population [Abstract]. Society of Gynecologic Oncologists (SGO) 41st Annual Meeting on Women’s Cancer, San Francisco, California, March 14-17th, 2010.
  18. Patel AA, Spiker WR, Daubs M, Brodke DS, Cannon-Albright LA (2010). Evidence of an Inherited Predisposition for Cervical Spondylosis with Myelopathy [Abstract]. American Academy of Orthopaedic Surgeons, New Orleans, Louisiana, March 9-13th 2010.
  19. Patel A, Spiker W, Bordke D (2009). Evidence of an Inherited Predisposition to the Development of Lumbar Disk Herniation [Abstract]. The Lumbar Spine Research Society Meeting, Chicago, Illinois, April 2nd, 2009.
  20. Abo R, Cai Z, Lin WY, Graeme G, Rigas SH, Bishop DT, Cannon-Albright LA, Neal DE, Donovan JL, Hamdy FC, Cox A, Camp NJ (2009). Identification of a Shared CASP8 Haplotype Associated with Multiple Common Cancers [Abstract]. 59th Annual American Society of Human Genetics Meeting, Honolulu, Hawaii, October 10-24th, 2009.
  21. Viskochil D, Cannon-Albright LA, Stevenson D (2009). Relative Risks for Cancers in the Neurofibromatosis Population in Utah [Abstract]. 15th Annual Meeting of the Connective Tissue Oncology Society, Miami Beach, Florida, November 5-7th, 2009.
  22. Patel AA, Spiker WR, Daubs M, Brodke DS, Cannon-Albright LA (2009). Evidence of an Inherited Predisposition for Cervical Spondylosis with Myelopathy [Abstract]. Cervical Spine Research Society Annual Meeting, Salt Lake City, Utah December 3-5th, 2009.
  23. Albright F, Teerlink C, Farnham JM, Backus S, Cannon-Albright LA (2009). Reconstituting Genealogical Information from a Multipurpose Data Resource [Abstract]. American Medical Informatics Association Annual Symposium, SanFrancisco, California, November 14-18, 2009.
  24. Cox A, Lin W, Elliot G, Rigas SH, Bishop DT, Cannon-Albright LA, Camp NJ, Neal DE, Donovan JL, Hamdy FC (2009). An Investigation of the role of the caspase-8 gene in prostate and colon cancer susceptibility using a SNP-tagging approach [Abstract]. AACR 100th Annual Meeting, Denver, Colorado, April 18th - 22nd, 2009.
  25. Patel A, Spiker W, Daubs M, Brodke D, Cannon-Albright LA (2009). Evidence of an Inherited Predisposition to the Development of Lumbar Disk Herniation [Abstract]. Lumbar Spine Research Society Meeting, April, 2009, Chicago Illinois.
  26. Cannon-Albright LA (2009). Analysis of a Computerized Genealogy Linked to State-wide Cancer Data to Define Risks for Cancer Among Inbred Individuals [Abstract]. American Medical Informatics Association Summit on Translational Bioinformatics, San Francisco, California, March 15th-17th, 2009.
  27. Parks TN, Hunter LL, Cannon-Albright LA (2009). A population-based analysis of familiality in Auditory Processing Disorder [Abstract]. 32nd MidWinter Association for Research in Otolaryngology Meeting, Baltimore, Maryland, February 14th-19th, 2008.
  28. Tashjian R, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright LA (2009). Evidence for an Inherited Predisposition Contributing to the Risk for Rotator Disease; Presentation by Dr. Tashijan [Abstract]. American Academy of Orthopaedic Surgeons 76th Annual Meeting, Las Vegas, Nevada, February 25th -28th, 2009.
  29. Krikov S, Price RC, Allen-Brady K, Cannon-Albright L, Facelli JC (2008). Enabling GeneHunter as a grid service: a case study for implementing analytical services for biomedical grids [Abstract]. AMIA Annu Symp Proc, 1014.
  30. Christensen GB, Farnham JM, Camp NJ, Cannon-Albright LA (2008). Combined Genome-wide Linkage and Association Analysis of extended Utah prostate cancer pedigrees identifies significance at 8q12 [Abstract]. International Genetic Epidemiology Society, St Louis, Missouri, September 15th-16th, 2008.
  31. Allen-Brady K, Norton PA Farnham J, Cannon-Albright LA (2008). Significant Linkage Evidence for a Pelvic Floor Predisposition Gene on Chromosome 9. Voted "Best non-clinical research presentation Award" for the 38th Annual International Continence Society Meeting, Egypt, Cairo,Oct 20-24, 2009 [Abstract]. American Urogynecologic Society, 29th Annual Scientific Meeting , Chicago, IL, September 4th-6th, 2008; International Genetic Epidemiology Society, St Louis, MO, September 15th-16th, 2008; 38th Annual International Continence Society Meeting, Egypt, Cairo, October 20th-24th, 2008.
  32. Christensen GB, Farnham J, Camp, Cannon-Albright LA (2008). Combined Genome-wide Linkage and Association Analysis of extended Utah prostate cancer pedigrees identifies significance at 8q12 [Abstract]. American Society of Human Genetics Meeting, Philadelphia, Pennsylvania, November 11th-15th, 2008; 17th Annual Meeting of the International Genetic Epidemiology Society, Saint Louis, Missouri, September 14th-16th, 2008.
  33. Farnham J, Leachman S, Camp NJ, Cannon-Albright LA (2008). Genome-wide case control association study for familial Melanoma identifies 2 significant associations [Abstract]. International Genetic Epidemiology Society, St. Louis, Missouri, September 15th-16th, 2008; American Society of Human Genetics, Philadelphia, Pennsylvania, November 11th-15th, 2008.
  34. Teerlink CC, Hegewald MJ, Cannon-Albright LA (2008). Assessing the risk of asthma in relatives of cases in the Utah population [Abstract]. 4th Annual Utah Health Services Research Conference, Salt Lake City, Utah, April 25th, 2008.
  35. Krikov S, Price R, Allen-Brady K, Cannon-Albright LA, Facelli JC (2008). Enabling GeneHunter as a Grid Service: A Case Study for Implementing Analytical Services for Biomedical Grids [Abstract]. AMIA Fall Conference, Savannah, California November, 2008.
  36. Shephard N, Brock I, Camp NJ, Cannon-Albright LA, Frank B, Burwinke B, Cox A (2008). A multi-centre study of CASP8 polymorphisms in breast cancer [Abstract]. Breast Cancer Campaign Conference, Breast Cancer Research, The Royal Society London, UK, May 2008, 10(suppl 2), P51.
  37. Curtin K, Cox A, Cannon-Albright LA, Camp NJ (2008). The role of disease-based discovery panels in tSNP selection [Abstract]. American Association for Cancer Research Annual Meeting, San Diego, CA, April 12th -16th, 2008.
  38. Norton PA, Nygaard I, Cannon-Albright LA (2007). The heritability of pelvic organ prolapse [Abstract]. Society of Gynecologic Surgeons Thirty-Third Scientific Meeting Orlando, Florida, April 12th -14th,2007.
  39. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2007). Shared genomic segment analysis.  A novel approach to mapping disease predisposition genes in extended pedigrees using dense single nucleotide polymorphism assays [Abstract]. International Genetic Epidemiology Society 16th Annual Meeting, York, England. September 7th-10th, 2007.
  40. Randall RL, Lessnick SL, Kerber R, Coffine CM, Scaife C, Andbacka R, Cannon-Albright LA (2007). A heritable contribution to malignant fibrous sarcomas [Abstract]. Musculoskeletal Tumor Society, Saint Louis, Missouri, May, 2007. 75th Annual Meeting of the American Academy of Othopedic Surgeons, San Francisco, California, March 5th-8th, 2008. 121st American Orthopeadic Association/63rd Canadian Orthopaedic Association annual meeting,Québec City, Québec, Canada, June 4th-7th, 2008.
  41. Randall RL, Lessnick SL, Kerber R, Virshup D, Coffin CM, Chen LL, Cannon-Albright LA (2007). Familial Clustering of Ewing's Sarcoma Observed in a Population-based Resource [Abstract]. 14th International Symposium on Limb Salvage, Hamburg, Germany, September 11th-14th, 2007. 75th Annual Meeting of the American Academy of Othopedic Surgeons, San Francisco, California, March 5th-8th, 2008. 121st American Orthopeadic Association annual meeting,Québec City, Québec, Canada, June 4th-7th, 2008.
  42. Matthews RD, Neumayer LA, Cannon-Albright LA (2007). Non-Medullary Thyroid Cancer and Relative Risk of Other Malignancy: An Analysis of the Utah Population Database and Utah Cancer Registry [Abstract]. 28th American Association of Endocrine Surgeons Annual Meeting, Tucson, Arizona, April 29 - May 1, 2007.
  43. Jackson HH, Galsgow RE, Mulvihill SJ, Cannon-Albright LA (2007). Familial Risk in Gallbladder Cancer [Abstract]. American College of Surgeons Surgical Forum, Las Vegas, Nevada, April, 2007.
  44. Farnham JM, Camp NJ, Thomas A, Cannon-Albright LA (2007). A Method to Calculate the Approximate Density of SNPs Required for Successful Linkage Studies [Abstract]. International Genetic Epidemiology Society Meeting. York, England, September 7th-10th, 2007.
  45. Christensen GB, Camp NJ and the ICPCG (2007). Focusing on Linked Pedigrees for Localizing Disease Genes: the sumLINK Statistic Applied to General and Aggressive Prostate Cancer Linkage Data from the ICPCG [Abstract]. American Society of Human Genetics 57th Annual Meeting, San Diego, California, Octotber 23rd - 27th, 2007.
  46. Christensen GB, Camp NJ, and the ICPCG (2007). The sumLINK statistic for linkage analysis: An application to the ICPCG pooled linkage resource [Abstract]. International Genetic Epidemiology Society 16th Annual Meeting, York, England. September 7th - 10th, 2007.
  47. Cannon-Albright LA, Nygaard I, Norton P (2007). The Heritable Contributions to Lower Urinary Tract Symptoms [Abstract]. International Genetic Epidemiology Society 16th Annual Meeting, York, England, September 7th - 10th, 2007.
  48. Camp NJ, Farnham JM, Cannon-Albright LA (2007). Strong Evidence for a Genetic Component to Multiple Myeloma and Pleiotrophy with other Hematologic Malignancies [Abstract]. American Society of Human Genetics Meeting, San Diego, CA. October, 23rd-27th, 2007.
  49. Camp NJ, Werner TL, Cannon-Albright LA (2007). Multiple Myeloma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Evidence for Overlapping Genetic Etiologies [Abstract]. International Genetic Epidemiology Society 16th Annual Meeting, York, England, September 7th-10th, 2007.
  50. Camp NJ, Farnham JM, Cannon-Albright LA (2007). Further localization of the 8q24 prostate cancer locus to a 2.0 Mb region using Utah extended pedigrees.σ [Abstract]. 98th American Association for Cancer Research Annual Meeting, Los Angeles, California, April 14th-18th, 2007.
  51. Camp NJ, Werner TL, Cannon-Albright LA (2007). The Familiality of Multiple Myeloma in the Utah Population Database [Abstract]. 98th AACR Annual Meeting, Los Angeles, California, April 14th-18th, 2007.
  52. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2006). Genome-wide Linkage Analysis for Aggressive Prostate Cancer in Utah High Risk Pedigrees [Abstract]. American Society of Human Genetics, New Orleans, Louisiana, October 9th - 13th, 2006.
  53. Christensen GB, Farnham JM, Camp NJ, Cannon-Albright LA (2006). Survey of Excess Familiarity in Prostate Cancer [Abstract]. National Library of Medicine Informatics Training Meeting, Nashville, Tennessee, June 27th - 28th, 2006.
  54. Cannon-Albright LA (2006). Unique Utah Resources for Cancer Genetics Research (a Genetic Epidemiology Perspective) [Abstract]. CCSG Annual Retreat, Salt Lake City, Utah, September 2007.
  55. Cannon-Albright LA (2006). National Invited Presentations: Genotypes and Phenotypes: Databases and Diagnosis [Abstract]. United States Pharmacopeia Drug Information Consultation II Meeting, North Bethesda, Maryland, August 22nd, 2006.
  56. Cannon-Albright LA (2006). International Invited Presentation: Prostate cancer studies in Utah and the 22q locus [Abstract]. Prostate Cancer Research Foundation Symposium, London, England.
  57. Cannon-Albright LA (2006). Utah genealogical database [Abstract]. Invited Presentation at the Family Based Studies and Genetic Epidemiology: Theory and Practice Symposium, Sheffield, England.
  58. Albright FS, Orlando PL, Cannon-Albright LA (2006). Evidence for a heritable Component to Death from Influenza in the Utah Population [Abstract]. American Society of Human Genetics, New Orleans, Louisiana, October 9th - 13th, 2006.
  59. Teerlink C, Cannon-Albright LA (2006). A genealogical assessment of heritable predisposition to asthma mortality [Abstract]. American Society of Human Genetics Meeting, New Orleans, Louisiana, October 9th - 13th, 2006.
  60. Allen-Brady K, Cannon-Albright LA (2006). Early age-at-diagnosis is a characteristic of familial lobular breast carcinoma [Abstract]. 15th International Genetic Epidemiology Society Meeting, St. Pete Beach, Tampa Bay, Florida, November 16th - 17th, 2006.
  61. Camp NJ, Farnham JM, Cannon-Albright LA (2006). Localization of a Prostate Cancer Predisposition Gene to an 880 kilobase region on 22q12.2 in Utah High-Risk Pedigrees [Abstract]. 15th International Genetic Epidemiology Society Meeting, St. Pete Beach, Tampa Bay, Florida, November 16th - 17th, 2006.
  62. Allen-Brady K, Farnham JM, Camp NJ, Ostrander EA, Karlins E, Cannon-Albright LA (2006). BRCA2 mutations in Utah high-risk prostate cancer pedigrees [Abstract]. American Society of Human Genetics Meeting, New Orleans, Louisiana, October 9th - 13th, 2006.
  63. Cannon-Albright LA, Farnham JM, Camp NJ (2006). Localization of a Prostate Cancer Predisposition Gene to a 416,515 bp Region on Chromosome Xq28 in Utah High-Risk Pedigrees [Abstract]. American Society of Human Genetics, New Orleans, Louisiana, October 9th - 13th, 2006.
  64. Teerlink C, Camp NJ, Cannon-Albright LA (2006). Genome-wide linkage analysis for asthma predisposition loci in extended Utah pedigrees [Abstract]. 15th International Genetic Epidemiology Society Meeting, St. Pete Beach, Tampa Bay, Florida, November 16th - 17th, 2006.
  65. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2006). Genetic susceptibility of Prostate Cancer: Genome-wide screen of men with "non-aggressive" disease [Abstract]. 15th International Genetic Epidemiology Society Meeting, St. Pete Beach, Tampa Bay, Florida, November 16th - 17th, 2006.
  66. Cannon-Albright LA (2006). Evidence for a heritable component to Chronic Fatigue Syndrome. 25th Annual American Pain Society Mtg, 2006 [Abstract]. J Pain, 7(4), Supple2, PS105.
  67. Albright FS, Orlando PL, Pavia A, Cannon-Albright LA (2006). Suggestive Evidence for a genetic component for predisposition to death by influenza from a genealogy linked to 100 years of Utah death certificate data [Abstract]. American Medical Informations Spring Symposium, Phoenix, Arizona, May, 2006.
  68. Cannon-Albright LA, Farnham JM, Camp NJ (2005). Using a Utah pseudo isolate population to identify predisposition genes for prostate cancer [Abstract]. Second International Meeting on Genetics of Complex Diseases and Isolated Populations. Paestum, Italy. May 28th - 31st, 2005.

Other

  1. Del Risco Kollerud R, Blaasaas KG, Claussen B, Nafstad P, Cannon-Albright LA, Ruud E, Wesenberg F, Naess O (2018). Family history of cancer and the risk of childhood solid tumours: a Norwegian nationwide register-based cohort study. Br J Cancer (118(6), pp. 905-912). England.
  2. Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K, Easton DF, Eeles RA, Kote-Jarai Z (2018). Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer (118(6), pp. e9). England.
  3. Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Murcia JDG, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, Hardy J, Munger R, Norton M, Sassi C, Singleton A, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Cruchaga C, Goate AM, Corcoran C, Tschanz J, Cannon-Albright LA, Kauwe JSK (2018). Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome Med (10(1), p. 4). England.
  4. Tashjian RZ, Granger EK, Farnham JM, Cannon-Albright LA, Teerlink CC (2016). Erratum to "Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms" [J Shoulder Elbow Surg 2016;25:174-179]. J Shoulder Elbow Surg (25(10), p. 1731). United States.
  5. Teerlink CC, Cannon-Albright LA, Tashjian RZ (2016). Erratum to "Significant association of full-thickness rotator cuff tears and estrogen-related receptor-beta (ESRRB)" [J Shoulder Elbow Surg 2015;24:e31-e35]. J Shoulder Elbow Surg (25(5), p. 864).
  6. Piepkorn M, Cannon-Albright LA, Meyer LJ, Goldgar DE, Zone JJ, Skolnick MH (1994). Genetic predisposition to melanoma. The Melanoma Letter (12(2), pp. 1-4).

Poster

  1. Schiffman J, Demarest B, Cannon-Albright L, Viskochil D, Stevenson D (November 2010). Copy number variation as a marker of genomic instability and disease severity in Neurofibromatosis Type 1 (NF1). Poster session presented at 60th Annual Meeting of the American Society of Human Genetics (ASHG), Washington D.C.